A Glycemia-Based Nomogram for Predicting Outcome in Stroke Patients after Endovascular Treatment.

ABSTRACT: Objective: Higher fasting glucose is thought to be associated with adverse outcome in patients receiving endovascular treatment (EVT), while the effect of glycosylated hemoglobin (HbA_1c) on outcome is controversial. We combined fasting blood glucose (FBG) with HbA_1c and evaluated their relationship with the three-month functional outcome in patients who underwent EVT. Methods: Data from 739 consecutive ischemic stroke patients who underwent EVT from April 2015 to August 2021 were retrospectively reviewed. HbA_1c was used to estimate the chronic glucose level according to the following formula: chronic glucose level (mg/dL) = 28.7 × HbA_1c (%) - 6.7. Patients were split into two groups in accordance with the three-month modified Rankin

SUBMITTER: Liu C 

PROVIDER: S-EPMC9688182 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature